Improving care for cancer of unknown primary
Part of Cancer clinical trials.
This study is for people with cancer that has spread to other parts of the body but where doctors cannot find the original tumor (called cancer of unknown primary). The trial aims to improve prediction of how the cancer will behave and to personalize treatment. Participants will have a biopsy of the metastatic area, and researchers will use this to better understand the cancer and guide treatment options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cancer that has spread to other parts of your body, and doctors have not been able to find where it originally started.
- You are well enough to be up and about for at least part of the day (performance status 0-2).
- You are expected to live for at least 3 more months.
- You have had imaging scans (like CT or PET) that show the cancer has spread, but no primary tumor was found.
- A biopsy of the metastatic area has been done or can be done, confirming the cancer type.
- You are able to give signed consent to participate and follow the study rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug (F520) combined with two chemotherapy drugs for people whose cancer started in an unknown place in the body. It aims to see if the combination shrinks tumors and is safe.
This study looks at people with rare solid tumors or lymphoma to understand their cancer’s genetic changes. It collects blood and existing tissue samples (from standard care) for DNA testing and gathers health information to help improve knowledge about rare cancers.
This study tests a special PET scan that may help find where a cancer that started somewhere unknown originated. It could help doctors choose the right treatment by locating the hidden primary tumor.
This trial is for people whose cancer started in an unknown place (cancer of unknown primary). It uses a special test called PaCIFiC-CUP to help classify the cancer, which may guide better treatment choices.
This trial is for people with cancer of unknown primary (CUP), meaning cancer that started in an unknown place in the body. It aims to use advanced genomic testing (looking at your tumor's DNA) on your stored tumor sample and blood to find clues about where the cancer began and possible treatment options.
This trial tests a radioactive medicine (Lu-177 FAP-2286) that seeks out and delivers radiation directly to cancer cells. It is for people whose cancer started in an unknown place and has not responded to their first chemotherapy.
Hear when a new Cancer of Unknown Primary Site trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.